↓ Skip to main content

Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, July 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
29 Mendeley
Title
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals
Published in
European Journal of Nuclear Medicine and Molecular Imaging, July 2014
DOI 10.1007/s00259-014-2838-z
Pubmed ID
Authors

C. Decristoforo, I. Penuelas, P. Elsinga, J. Ballinger, A. D. Winhorst, A. Verbruggen, F. Verzijlbergen, A. Chiti

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 3%
Austria 1 3%
Unknown 27 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 21%
Professor 5 17%
Student > Master 4 14%
Student > Doctoral Student 3 10%
Other 3 10%
Other 6 21%
Unknown 2 7%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 10 34%
Chemistry 5 17%
Medicine and Dentistry 5 17%
Physics and Astronomy 2 7%
Agricultural and Biological Sciences 2 7%
Other 3 10%
Unknown 2 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2015.
All research outputs
#18,541,858
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#2,210
of 3,083 outputs
Outputs of similar age
#157,463
of 229,143 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#20
of 37 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,143 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.